In addition to METTL3, METTL14, ALKBH5, and YTHDF1/2 also exhibited both oncogenic and anti-oncogenic effects in lung cancer (Gao et al., 2023[58]; Hua et al., 2024[85]; Ji et al., 2024[101]; Li et al., 2022[125]; Sun et al., 2022[227]; Tsuchiya et al., 2021[237]; Dou et al., 2022[50]). Here, YTHDF1 is linked to lung cancer.